 |
인쇄하기
취소
|
Kolmar Korea in tie-up with Pharmascience
Kolmar Korea, one of the nation’s innovative pharmaceutical firms, said Saturday it has signed an agreement with Pharmascience Inc. to establish Pharmascience Korea, a joint venture firm here in 2014.
Pharmascience Korea will be 50 percent owned by each side, according to Kolmar Korea.
Commenting on the new joint venture, David Goodman, Chairman and CEO of Pharmascience, said:
“The new...
Pharmascience Korea will be 50 percent owned by each side, according to Kolmar Korea.
Commenting on the new joint venture, David Goodman, Chairman and CEO of Pharmascience, said:
“The new...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.